The clinical stages, classifications and new therapeutic strategies of hypertension
- Author:
Jia-rong TANG
1
;
Dao-wen WANG
1
Author Information
- Publication Type:Journal Article
- Keywords: hypertension; guidelines; risk stratification; antihypertensive therapy; primary; secondary
- From: Chinese Journal of Practical Internal Medicine 2019;39(01):11-15
- CountryChina
- Language:Chinese
- Abstract: In the 2017 AHA Hypertension Guidelines, BP≥130/80 mm Hg was used as the new diagnostic criterion for hypertension, and risk stratification was emphasized according to the 10-year CVD risk. Lifestyle intervention, without pharmacological treatment, was recommended for low-risk patients whose BP≥130/80 mmHg. However, high risk patients should receive antihypertensive pharmacological treatment as soon as their BP≥130/80 mmHg. In the 2018 European Guidelines for the management of hypertension, the definition and classification of office hypertension still followed the standard of the 2013's edition, but more aggressive therapeutic strategies were recommended.Hypertension can be divided into primary hypertension and secondary hypertension. To screen and diagnose secondary hypertension, it is necessary not only to construct a systematic and standardized method to avoid missed diagnosis and misdiagnosis but also to avoid screening blindly.
